Back to Journals » Therapeutics and Clinical Risk Management » Volume 5

Biphosphonates-related osteonecrosis of the jaw: Clinical and physiopathological considerations

Authors Borgioli A, Viviani C, Duvina M, Brancato L, Spinelli G, Brandi ML, Tonelli P

Published 27 February 2009 Volume 2009:5 Pages 217—227


Alberto Borgioli1, Christian Viviani1, Marco Duvina1, Leila Brancato1, Giuseppe Spinelli1, Maria Luisa Brandi2,3, Paolo Tonelli1
1Department of Odontostomatology, Dental School; 2Department of Internal Medicine; 3DeGene Spin-off, Medical School, University of Florence, Florence, Italy

Abstract: Since osteonecrosis of the jaw was related to biphosphonate administration by Marx, studies showing clinical symptoms, drug and surgical therapies overwhelmed the literature. Furthermore, the literature demonstrated the correlation between chronic biphosphonate adsumption and osteonecrosis of the jaw onset. Nitrogen-containing biphosphonates are widely used for the management of metastatic cancer, for prevention and treatment of osteoporosis, for the treatment of Paget’s disease, and for the management of acute hypercalcemia. According to our experience, the treatment of BRON-J’s lesions is difficult and prolonged. For this reason, in order to avoid these complications it is mandatory to perform a risk staging in patients who must undergo biphosphonate administration. When pharmacologic treatments with antibiotics and local antiseptics are not able to control the development of BRON-J’s complications, the clinicians should perform radical surgical treatments such as the resection of the bone involved.

Keywords: osteonecrosis of the jaw, biphosphonates, BRON-J

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]